Author

P. Eisenhauer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

J. W. Botten· 2 shared A. Falcone· 1 shared A. K. Ramesh· 1 shared A. M. Schmoker· 1 shared A. W. Womack· 1 shared A. Whitaker· 1 shared B. A. Ballif· 1 shared B. A. Keyt· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. W. Botten

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV

H. Guo, B. Cho, P. R. Hinton, S. He, Y. Yu, A. K. Ramesh, J. P. Sivaccumar, Z. Ku, K. Campo, S. Holland, S. Sachdeva, C. Mensch, M. Dawod, A. Whitaker, P. Eisenhauer, , T.-M. Fu

This paper introduces an ACE2 decamer viral trap that neutralizes multiple SARS-CoV-2 variants and related coronaviruses through inhalation, showing durability and effectiveness in preclinical models.

bioRxiv · Jul 10, 2023Microbiology

A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral budding and cytopathogenicity

I. Manuelyan, A. M. Schmoker, B. L. Yount, P. Eisenhauer, J. I. Keller, C. Gold, D. Terino, C. M. Ziegler, J. Alexander, H. E. Driscoll, E. Hutchinson, D. Bhella, C. D. Syme, D. G. Widman, M. T. Heise, , J. W. Botten

This study maps host-driven post-translational modifications on the Zika virus proteome, identifies key phosphosites, and shows how an FDA-approved kinase inhibitor blocks viral growth.

bioRxiv · Nov 24, 2021 · PreprintMicrobiology